Cannara Biotech Inc.
LOVE.TO
TSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.32% | 75.55% | 100.52% | 182.88% | 109.88% |
| Total Depreciation and Amortization | -1.18% | 4.05% | 2.78% | 2.25% | 11.34% |
| Total Amortization of Deferred Charges | -24.84% | -65.93% | -82.37% | 8.28% | 8.28% |
| Total Other Non-Cash Items | 454.32% | 1,355.60% | 3,088.71% | -91.05% | -186.89% |
| Change in Net Operating Assets | 88.88% | -387.03% | -185.13% | 51.93% | 14.05% |
| Cash from Operations | 148.90% | 34.49% | 77.18% | 84.08% | 19.35% |
| Capital Expenditure | -83.48% | -60.64% | 17.09% | 40.57% | 25.68% |
| Sale of Property, Plant, and Equipment | -86.07% | -92.69% | -92.56% | -98.66% | 1,618.27% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.28% | 55.21% | 47.97% | 23.59% | 20.39% |
| Cash from Investing | -177.95% | -150.18% | -11.59% | 22.12% | 51.79% |
| Total Debt Issued | -100.00% | -100.00% | -91.23% | -93.06% | -58.46% |
| Total Debt Repaid | 16.38% | 33.86% | 33.94% | 35.00% | -98.67% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 23.28% | 10.48% | 12.54% | 25.13% | 42.57% |
| Cash from Financing | 105.46% | -31.20% | -74.75% | -104.91% | -135.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 673.58% | -18.76% | 225.64% | 510.47% | 314.47% |